Breaking News Instant updates and real-time market news.

16:00
08/15/19
08/15
16:00
08/15/19
16:00

Treasury Market Summary

Treasury Market Summary: yields plunged, sending the bond below the 2% for the first time ever, and a new all-time low at 1.914%. The 10-year dropped to 1.47% and the 2-year tested 1.46%, before rates edged up slightly. The curve steepened out over 3 bps. While the latter helped support equities, trading was very choppy. Also impacting the markets Thursday were a mix of trade comments from China, with some conciliatory remarks underpinning equities. Also, ECB's Rehn's call for "impactful and significant" stimulus in a WSJ interview added to the drop in yields. Meanwhile, better than expected retail sales and productivity data, and a solid earnings beat from Walmart boosted equities. Wall Street pared its gains and fell into the red as the 10-year yield fell below the 1.50% mark, but it bounced and stocks recovered slightly, though an anxious tone prevailed. The Bank of Mexico surprised somewhat with a 25 bp cut to an 8.00% policy rate. View the summary.

TODAY'S FREE FLY STORIES

Recommendations
NGM Biopharmaceuticals' four pipeline programs underappreciated, says Piper » 20:57
08/12/20
08/12
20:57
08/12/20
20:57
NGM

NGM Biopharmaceuticals

$18.57 /

-0.32 (-1.69%)

Piper Sandler analyst…

Piper Sandler analyst Yasmeen Rahimi keeps his Overweight rating and $30 price target on NGM Biopharmaceuticals after its Q2 results. The analyst is positive on the company disclosing a "totality of progress" in its enriched development pipeline along with its specific upcoming catalysts. Rahimi adds that at "only" $1.28B market cap, investors are underappreciating NGM's four distinct pipeline programs in liver, metabolic, ophthalmology and cancer.

ShowHide Related Items >><<
NGM NGM Biopharmaceuticals
$18.57 /

-0.32 (-1.69%)

NGM NGM Biopharmaceuticals
$18.57 /

-0.32 (-1.69%)

07/30/20 Piper Sandler
NGM Biopharmaceuticals initiated with an Overweight at Piper Sandler
07/07/20 Chardan
NGM Biopharmaceuticals initiated with a Buy at Chardan
06/04/20 BMO Capital
NGM Biopharmaceuticals initiated with an Outperform at BMO Capital
05/06/20 Stifel
Stifel says semaglutide data a 'slight positive' for NGM Biopharmaceuticals
NGM NGM Biopharmaceuticals
$18.57 /

-0.32 (-1.69%)

NGM NGM Biopharmaceuticals
$18.57 /

-0.32 (-1.69%)

NGM NGM Biopharmaceuticals
$18.57 /

-0.32 (-1.69%)

Upgrade
Purplebricks upgraded to Buy from Neutral at UBS » 20:43
08/12/20
08/12
20:43
08/12/20
20:43
PRPPF

Purplebricks

$0.00 /

+ (+0.00%)

UBS upgraded Purplebricks…

UBS upgraded Purplebricks to Buy from Neutral with a price target of 100 GBp, up from 44 GBp.

ShowHide Related Items >><<
PRPPF Purplebricks
$0.00 /

+ (+0.00%)

08/03/20 Peel Hunt
Purplebricks upgraded to Buy from Add at Peel Hunt
06/10/20 JPMorgan
Purplebricks price target raised to 53 GBp from 50 GBp at JPMorgan
Initiation
TCR2 Therapeutics initiated with a Buy at Truist » 20:40
08/12/20
08/12
20:40
08/12/20
20:40
TCRR

TCR2 Therapeutics

$16.76 /

-0.09 (-0.53%)

Truist analyst Asthika…

Truist analyst Asthika Goonewardene initiated coverage of TCR2 Therapeutics with a Buy rating and $40 price target.

ShowHide Related Items >><<
TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

08/12/20 Piper Sandler
TCR2 Therapeutics initiated with an Overweight at Piper Sandler
07/27/20 H.C. Wainwright
TCR2 Therapeutics price target raised to $33 from $19 at H.C. Wainwright
07/27/20 Roth Capital
TCR2 Therapeutics upgraded to Buy from Neutral at Roth Capital
07/27/20 Wedbush
TCR2 Therapeutics price target raised to $32 from $25 at Wedbush
TCRR TCR2 Therapeutics
$16.76 /

-0.09 (-0.53%)

  • 29
    Jul
Syndicate
Newgioco Group 4.17M share Spot Secondary priced at $2.40 » 20:38
08/12/20
08/12
20:38
08/12/20
20:38
NWGI

Newgioco Group

$2.85 /

+0.09 (+3.26%)

The deal priced below the…

The deal priced below the last closing price of $2.67. Maxim is acting as sole book running manager for the offering.

ShowHide Related Items >><<
NWGI Newgioco Group
$2.85 /

+0.09 (+3.26%)

Initiation
Oric Pharmaceuticals initiated with an Outperform at Baird » 20:37
08/12/20
08/12
20:37
08/12/20
20:37
ORIC

Oric Pharmaceuticals

$25.41 /

+0.01 (+0.04%)

Baird analyst Michael Ulz…

Baird analyst Michael Ulz initiated coverage of Oric Pharmaceuticals with an Outperform rating and $45 price target.

ShowHide Related Items >><<
ORIC Oric Pharmaceuticals
$25.41 /

+0.01 (+0.04%)

ORIC Oric Pharmaceuticals
$25.41 /

+0.01 (+0.04%)

08/06/20 Citi
Oric Pharmaceuticals upgraded to Buy on valuation at Citi
08/06/20 Citi
ORIC Pharmaceuticals upgraded to Buy from Neutral at Citi
08/03/20
Fly Intel: Top five analyst initiations
08/03/20 H.C. Wainwright
ORIC Pharmaceuticals initiated with a Buy at H.C. Wainwright
ORIC Oric Pharmaceuticals
$25.41 /

+0.01 (+0.04%)

  • 24
    Apr
ORIC Oric Pharmaceuticals
$25.41 /

+0.01 (+0.04%)

Earnings
Notable companies reporting before tomorrow's open » 20:25
08/12/20
08/12
20:25
08/12/20
20:25
IIVI

II-VI

$52.03 /

+1.1 (+2.16%)

, TPR

Tapestry

$15.57 /

+0.03 (+0.19%)

Notable companies…

Notable companies reporting before tomorrow's open, with earnings consensus, include II-VI (IIVI), consensus 77c... Tapestry (TPR), consensus (57c).

ShowHide Related Items >><<
TPR Tapestry
$15.57 /

+0.03 (+0.19%)

IIVI II-VI
$52.03 /

+1.1 (+2.16%)

IIVI II-VI
$52.03 /

+1.1 (+2.16%)

07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/23/20 Loop Capital
II-VI initiated with a Buy at Loop Capital
07/15/20 Benchmark
II-VI price target raised to $60 from $51 at Benchmark
07/06/20 JPMorgan
II-VI shares offer 25% upside potential, says JPMorgan
TPR Tapestry
$15.57 /

+0.03 (+0.19%)

07/27/20
Fly Intel: Top five analyst upgrades
07/27/20 Goldman Sachs
Tapestry upgraded to Buy from Neutral at Goldman Sachs
05/07/20
Fly Intel: Top five analyst upgrades
05/07/20 HSBC
Tapestry upgraded to Buy from Hold at HSBC
TPR Tapestry
$15.57 /

+0.03 (+0.19%)

IIVI II-VI
$52.03 /

+1.1 (+2.16%)

  • 02
    Jul
TPR Tapestry
$15.57 /

+0.03 (+0.19%)

IIVI II-VI
$52.03 /

+1.1 (+2.16%)

TPR Tapestry
$15.57 /

+0.03 (+0.19%)

IIVI II-VI
$52.03 /

+1.1 (+2.16%)

TPR Tapestry
$15.57 /

+0.03 (+0.19%)

Syndicate
TFI International 4.4M share Secondary priced at $43.25 » 20:24
08/12/20
08/12
20:24
08/12/20
20:24
TFII

TFI International

$43.97 /

-0.58 (-1.30%)

The deal size was…

The deal size was increased to 4.4M shares from 4.0M and priced below the last closing price of $43.98. Morgan Stanley, BofA, Credit Suisse, Goldman Sachs and JPMorgan are acting as joint book running managers for the offering.

ShowHide Related Items >><<
TFII TFI International
$43.97 /

-0.58 (-1.30%)

TFII TFI International
$43.97 /

-0.58 (-1.30%)

07/29/20 CIBC
TFI International price target raised to $61 from $55 at CIBC
07/29/20 RBC Capital
TFI International price target raised to C$62 from C$53 at RBC Capital
07/29/20 BMO Capital
TFI International price target raised to C$62 from C$54 at BMO Capital
07/29/20 Scotiabank
TFI International price target raised to C$65 from C$54 at Scotiabank
  • 13
    Aug
  • 13
    Feb
Recommendations
Postal Realty Trust holding up well in current environment, says BMO Capital » 20:07
08/12/20
08/12
20:07
08/12/20
20:07
PSTL

Postal Realty Trust

$15.14 /

-0.23 (-1.50%)

BMO Capital analyst Frank…

BMO Capital analyst Frank Lee keeps his Outperform rating and $18 price target on Postal Realty Trust after its Q2 results. The company is holding up well under the current environment as the quarter topped expectations with 100% of rents collected, the analyst tells investors in a research note. Lee further states that Postal Realty's completed $52M follow-on offering in July and amended LOC allows for much needed capital to "help fuel future growth."

ShowHide Related Items >><<
PSTL Postal Realty Trust
$15.14 /

-0.23 (-1.50%)

PSTL Postal Realty Trust
$15.14 /

-0.23 (-1.50%)

06/04/20 BTIG
Postal Realty Trust initiated with a Buy at BTIG
12/18/19 Compass Point
Postal Realty Trust initiated with a Buy at Compass Point
12/18/19 Compass Point
Postal Realty Trust initiated with a Buy at Compass Point
12/18/19 Compass Point
Postal Realty Trust initiated with a Buy at Compass Point
PSTL Postal Realty Trust
$15.14 /

-0.23 (-1.50%)

  • 16
    Jul
PSTL Postal Realty Trust
$15.14 /

-0.23 (-1.50%)

Hot Stocks
BC Partners sells its remaining Altice USA stake of 17.3M shares of common stock » 19:53
08/12/20
08/12
19:53
08/12/20
19:53
ATUS

Altice USA

$27.36 /

+0.275 (+1.02%)

The company states:…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ATUS Altice USA
$27.36 /

+0.275 (+1.02%)

ATUS Altice USA
$27.36 /

+0.275 (+1.02%)

08/04/20 TD Securities
TD upgrades Altice USA to Buy on improving subscriber trends
08/04/20 TD Securities
Altice USA upgraded to Buy from Hold at TD Securities
08/03/20 Deutsche Bank
Altice USA price target raised to $40 from $34 at Deutsche Bank
08/03/20 UBS
Charter price target raised to $650 from $575 at UBS
ATUS Altice USA
$27.36 /

+0.275 (+1.02%)

  • 13
    Aug
  • 23
    Jun
  • 06
    May
  • 11
    Sep
  • 16
    Aug
ATUS Altice USA
$27.36 /

+0.275 (+1.02%)

ATUS Altice USA
$27.36 /

+0.275 (+1.02%)

Hot Stocks
II-VI to acquire Ascatron, outstanding interests in INNOViON, terms not stated » 19:35
08/12/20
08/12
19:35
08/12/20
19:35
IIVI

II-VI

$52.03 /

+1.1 (+2.16%)

The company states:…

The company states: "II-VI Incorporated announced that it has entered into a definitive agreement to acquire all the outstanding shares of Ascatron AB, a leader in silicon carbide epitaxial wafers and devices for power electronics. II-VI also announced that it will acquire all the outstanding interests of the owners of the parent of INNOViON Corporation, a leader in ion implantation technology for silicon and compound semiconductor devices. Both transactions are scheduled to close by the end of calendar year 2020. Ascatron produces state-of-the-art SiC epitaxial wafers and devices that enable a wide range of high-voltage power electronics applications. Ascatron is led by a team of experts in wide-bandgap materials with more than 200 person-years in the SiC and semiconductor industry, bringing world-class competence to SiC development and production processes."

ShowHide Related Items >><<
IIVI II-VI
$52.03 /

+1.1 (+2.16%)

IIVI II-VI
$52.03 /

+1.1 (+2.16%)

07/28/20 Raymond James
Corning results provide read-through to optical names, says Raymond James
07/23/20 Loop Capital
II-VI initiated with a Buy at Loop Capital
07/15/20 Benchmark
II-VI price target raised to $60 from $51 at Benchmark
07/06/20 JPMorgan
II-VI shares offer 25% upside potential, says JPMorgan
IIVI II-VI
$52.03 /

+1.1 (+2.16%)

  • 02
    Jul
IIVI II-VI
$52.03 /

+1.1 (+2.16%)

IIVI II-VI
$52.03 /

+1.1 (+2.16%)

Recommendations
Tela Bio price target raised to $17 from $14 at Piper Sandler » 19:22
08/12/20
08/12
19:22
08/12/20
19:22
TELA

Tela Bio

$13.00 /

-0.07 (-0.54%)

Piper Sandler analyst…

Piper Sandler analyst Matt O'Brien raised the firm's price target on Tela Bio to $17 from $14 and keeps an Overweight rating on the shares after the company reported Q2 results. O'Brien said that he believes Tela's business has continued to trend in the right direction even as COVID-19 has caused disruption, and he anticipates more of the same going forward.

ShowHide Related Items >><<
TELA Tela Bio
$13.00 /

-0.07 (-0.54%)

TELA Tela Bio
$13.00 /

-0.07 (-0.54%)

07/09/20 Piper Sandler
Piper recommends buying Tela Bio shares after 'strong' OviTex data
06/18/20 JMP Securities
Tela Bio price target raised to $24 from $20 at JMP Securities
06/10/20 Canaccord
Tela Bio price target raised to $20 from $15 at Canaccord
03/27/20 Piper Sandler
Demand for Tela Bio's OviTex/Hernia PRS 'encouraging,' says Piper Sandler
TELA Tela Bio
$13.00 /

-0.07 (-0.54%)

  • 26
    Jun
  • 08
    Nov
TELA Tela Bio
$13.00 /

-0.07 (-0.54%)

Downgrade
Nabors Industries downgraded to Sell from Neutral at Goldman Sachs » 19:21
08/12/20
08/12
19:21
08/12/20
19:21
NBR

Nabors Industries

$55.25 /

+1.505 (+2.80%)

Goldman Sachs analyst…

Goldman Sachs analyst Angie Sedita downgraded Nabors Industries to Sell from Neutral with a price target of $45, down from $65. The analyst anticipates negative free cash flows for the company in 2021 and 2022 while cutting her respective EBITDA estimates by 16% and 15% as she sees Nabors' International and North American markets continue to face challenges. Sedita adds that the company's rig count will increase beyond 500 rigs by the end of 2021, but remain about 28% below early 2020 levels and 42% below the 2019 average.

ShowHide Related Items >><<
NBR Nabors Industries
$55.25 /

+1.505 (+2.80%)

NBR Nabors Industries
$55.25 /

+1.505 (+2.80%)

08/03/20 Barclays
Barclays upgrades Nabors to Equal Weight on improved earnings outlook
08/03/20 Barclays
Nabors Industries upgraded to Equal Weight from Underweight at Barclays
07/10/20 AltaCorp
Nabors Industries downgraded to Underperform from Sector Perform at AltaCorp
07/08/20 Morgan Stanley
Morgan Stanley downgrades Nabors Industries to Underweight on balance sheet risk
NBR Nabors Industries
$55.25 /

+1.505 (+2.80%)

NBR Nabors Industries
$55.25 /

+1.505 (+2.80%)

Downgrade
BJ's Wholesale downgraded to Hold from Buy at Deutsche Bank » 19:07
08/12/20
08/12
19:07
08/12/20
19:07
BJ

BJ's Wholesale

$41.62 /

+0.955 (+2.35%)

Deutsche Bank analyst…

Deutsche Bank analyst Paul Trussell downgraded BJ's Wholesale to Hold from Buy.

ShowHide Related Items >><<
BJ BJ's Wholesale
$41.62 /

+0.955 (+2.35%)

BJ BJ's Wholesale
$41.62 /

+0.955 (+2.35%)

08/06/20 Credit Suisse
BJ's Wholesale assumed with an Outperform at Credit Suisse
07/30/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
07/29/20 MKM Partners
BJ's Wholesale initiated with a Sell at MKM Partners
07/21/20 Goldman Sachs
BJ's Wholesale price target raised to $43 from $38 at Goldman Sachs
BJ BJ's Wholesale
$41.62 /

+0.955 (+2.35%)

  • 17
    Jan
BJ BJ's Wholesale
$41.62 /

+0.955 (+2.35%)

BJ BJ's Wholesale
$41.62 /

+0.955 (+2.35%)

BJ BJ's Wholesale
$41.62 /

+0.955 (+2.35%)

Syndicate
Addus HomeCare 475K share Block Trade priced at $96.00 » 19:07
08/12/20
08/12
19:07
08/12/20
19:07
ADUS

Addus HomeCare

$98.53 /

-3.45 (-3.38%)

The deal range was…

The deal range was $95.75-$96.75. Jefferies acted as sole book running manager for the offering.

ShowHide Related Items >><<
ADUS Addus HomeCare
$98.53 /

-3.45 (-3.38%)

ADUS Addus HomeCare
$98.53 /

-3.45 (-3.38%)

08/12/20 BMO Capital
Addus HomeCare price target raised to $115 from $103 at BMO Capital
08/11/20 Oppenheimer
Addus HomeCare price target raised to $115 from $107 at Oppenheimer
06/17/20 Baird
Addus HomeCare price target raised to $100 from $96 at Baird
03/20/20 RBC Capital
RBC says Addus HomeCare selloff unwarranted as lockdowns don't apply
ADUS Addus HomeCare
$98.53 /

-3.45 (-3.38%)

  • 13
    Aug
  • 05
    Sep
Syndicate
Sprout Social 6M share Secondary priced at $27.50 » 19:07
08/12/20
08/12
19:07
08/12/20
19:07
SPT

Sprout Social

$29.35 /

+2.22 (+8.18%)

The deal priced below the…

The deal priced below the last closing price of $29.46. Morgan Stanley, Goldman Sachs, Barclays, KeyBanc and William Blair are acting as joint book running managers for the offering.

ShowHide Related Items >><<
SPT Sprout Social
$29.35 /

+2.22 (+8.18%)

SPT Sprout Social
$29.35 /

+2.22 (+8.18%)

06/29/20 Goldman Sachs
Sprout Social price target raised to $35 from $27 at Goldman Sachs
06/09/20
Fly Intel: Top five analyst initiations
06/08/20 BTIG
Sprout Social initiated with a Buy at BTIG
06/08/20 BTIG
Sprout Social initiated with a Buy at BTIG
SPT Sprout Social
$29.35 /

+2.22 (+8.18%)

  • 13
    Aug
  • 13
    Dec
SPT Sprout Social
$29.35 /

+2.22 (+8.18%)

Syndicate
Vertiv Holdings 20M share Secondary priced at $15.25 » 19:04
08/12/20
08/12
19:04
08/12/20
19:04
VRT

Vertiv Holdings

$15.76 /

-1.015 (-6.05%)

The deal prices below the…

The deal prices below the last closing price of $15.76. JPMorgan and Goldman Sachs are acting as joint book running managers for the offering.

ShowHide Related Items >><<
VRT Vertiv Holdings
$15.76 /

-1.015 (-6.05%)

VRT Vertiv Holdings
$15.76 /

-1.015 (-6.05%)

05/07/20 Deutsche Bank
Vertiv Holdings price target raised to $17 from $11 at Deutsche Bank
04/09/20 Deutsche Bank
Vertiv Holdings upgraded to Buy from Hold at Deutsche Bank
03/13/20
Fly Intel: Top analyst initiations
03/13/20 Goldman Sachs
Vertiv Holdings initiated with a Buy at Goldman Sachs
VRT Vertiv Holdings
$15.76 /

-1.015 (-6.05%)

  • 13
    Aug
On The Fly
Fly Intel: After-Hours Movers » 19:02
08/12/20
08/12
19:02
08/12/20
19:02
AZPN

Aspen Technology

$97.09 /

-0.22 (-0.23%)

, RVLV

Revolve Group

$19.49 /

+0.8 (+4.28%)

, STKS

One Group Hospitality

$1.95 /

+0.235 (+13.70%)

, ONEM

One Medical

$27.60 /

-0.87 (-3.06%)

, FOSL

Fossil

$4.64 /

-0.18 (-3.73%)

, ENS

EnerSys

$74.33 /

+0.195 (+0.26%)

, VRM

Vroom

$69.34 /

+4.45 (+6.86%)

, CSCO

Cisco

$48.08 /

+0.86 (+1.82%)

, VREX

Varex Imaging

$15.99 /

-0.29 (-1.78%)

, SDC

SmileDirectClub

$9.30 /

+0.35 (+3.91%)

, LYFT

Lyft

$30.58 /

-0.065 (-0.21%)

Check out this evening's…

Open Full Text

ShowHide Related Items >><<
VRM Vroom
$69.34 /

+4.45 (+6.86%)

VREX Varex Imaging
$15.99 /

-0.29 (-1.78%)

STKS One Group Hospitality
$1.95 /

+0.235 (+13.70%)

SDC SmileDirectClub
$9.30 /

+0.35 (+3.91%)

RVLV Revolve Group
$19.49 /

+0.8 (+4.28%)

ONEM One Medical
$27.60 /

-0.87 (-3.06%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

FOSL Fossil
$4.64 /

-0.18 (-3.73%)

ENS EnerSys
$74.33 /

+0.195 (+0.26%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

AZPN Aspen Technology
$97.09 /

-0.22 (-0.23%)

05/07/20 KeyBanc
Aspen Technology price target raised to $120 from $110 at KeyBanc
04/02/20 Baird
Aspen Technology downgraded to Neutral from Outperform at Baird
03/16/20 JPMorgan
Aspen Technology upgraded to Neutral from Underweight at JPMorgan
01/31/20 Baird
Aspen Technology weakness a buying opportunity, says Baird
RVLV Revolve Group
$19.49 /

+0.8 (+4.28%)

07/22/20 B. Riley FBR
Revolve well positioned for sales acceleration, says B. Riley FBR
06/09/20 Nomura Instinet
Revolve Group price target raised to $17 from $14 at Nomura Instinet
05/14/20 KeyBanc
Farfetch, Nordstrom, Revolve could be impacted by Amazon offering, says KeyBanc
05/14/20 B. Riley FBR
Revolve Group price target raised to $17 from $13 at B. Riley FBR
STKS One Group Hospitality
$1.95 /

+0.235 (+13.70%)

03/23/20 Lake Street
One Group Hospitality price target lowered to $1.50 from $5 at Lake Street
03/17/20 Piper Sandler
One Group Hospitality price target lowered to $2 from $4 at Piper Sandler
12/30/19 Lake Street
Alcohol sales suggest improved comps at One Hospitality's Kona, says Lake Street
09/04/19 Piper Sandler
One Group Hospitality downgraded to Neutral from Overweight at Piper Jaffray
ONEM One Medical
$27.60 /

-0.87 (-3.06%)

07/17/20 Piper Sandler
1Life Healthcare price target raised to $43 from $40 at Piper Sandler
07/08/20 Citi
1Life Healthcare price target raised to $38 from $20 at Citi
07/01/20 SVB Leerink
SVB Leerink starts 1Life with a Market Perform given unclear profitability path
07/01/20 SVB Leerink
1Life Healthcare initiated with a Market Perform at SVB Leerink
FOSL Fossil
$4.64 /

-0.18 (-3.73%)

11/07/19 KeyBanc
Fossil turnaround 'has not manifested,' says KeyBanc
11/07/19 KeyBanc
Fossil downgraded to Sector Weight from Overweight at KeyBanc
ENS EnerSys
$74.33 /

+0.195 (+0.26%)

06/15/20 BTIG
EnerSys initiated with a Neutral at BTIG
06/03/20 Oppenheimer
EnerSys price target raised to $80 from $75 at Oppenheimer
04/02/20 Oppenheimer
EnerSys price target lowered to $75 from $80 at Oppenheimer
VRM Vroom
$69.34 /

+4.45 (+6.86%)

08/06/20 Wedbush
Carvana price target raised to $170 from $125 at Wedbush
07/08/20 JPMorgan
Vroom initiated with a Neutral at JPMorgan
07/06/20 Wedbush
Wedbush bullish on Vroom, initiates with an Outperform
07/06/20 BofA
Vroom initiated with a Neutral at BofA
CSCO Cisco
$48.08 /

+0.86 (+1.82%)

08/07/20 Cleveland Research
Cisco checks point to 'disappointing pace' of recovery, says Cleveland Research
07/24/20 Wolfe Research
Cisco initiated with an Outperform at Wolfe Research
07/16/20
Fly Intel: Top five analyst downgrades
07/16/20 JPMorgan
JPMorgan downgrades Cisco, expects 'limited investor enthusiasm'
VREX Varex Imaging
$15.99 /

-0.29 (-1.78%)

05/13/20
Fly Intel: Top five analyst downgrades
05/13/20 JPMorgan
Varex Imaging downgraded to Neutral after 'mixed' Q2 at JPMorgan
05/13/20 JPMorgan
Varex Imaging downgraded to Neutral from Overweight at JPMorgan
03/25/20 JPMorgan
JPMorgan upgrades Varex Imaging to Overweight on 'unjustified' 35% selloff
SDC SmileDirectClub
$9.30 /

+0.35 (+3.91%)

07/29/20 Craig-Hallum
SmileDirectClub teen program should have immediate impact, says Craig-Hallum
07/12/20 Stifel
Stifel likes near-term setup for SmileDirectClub, ups price target to $11
06/25/20
Fly Intel: Top five analyst initiations
06/25/20 Stephens
Stephens starts SmileDirectClub at Overweight with $11 price target
LYFT Lyft
$30.58 /

-0.065 (-0.21%)

08/10/20 Jefferies
Lyft price target lowered to $40 from $50 at Jefferies
08/10/20 Credit Suisse
Lyft price target lowered to $66 from $75 at Credit Suisse
08/05/20 Deutsche Bank
Lyft price target lowered to $57 from $60 at Deutsche Bank
07/22/20 Raymond James
Lyft resumed with a Market Perform at Raymond James
VRM Vroom
$69.34 /

+4.45 (+6.86%)

VREX Varex Imaging
$15.99 /

-0.29 (-1.78%)

STKS One Group Hospitality
$1.95 /

+0.235 (+13.70%)

SDC SmileDirectClub
$9.30 /

+0.35 (+3.91%)

RVLV Revolve Group
$19.49 /

+0.8 (+4.28%)

ONEM One Medical
$27.60 /

-0.87 (-3.06%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

FOSL Fossil
$4.64 /

-0.18 (-3.73%)

ENS EnerSys
$74.33 /

+0.195 (+0.26%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

AZPN Aspen Technology
$97.09 /

-0.22 (-0.23%)

  • 25
    Jun
  • 09
    Jun
  • 31
    Jan
  • 12
    Sep
SDC SmileDirectClub
$9.30 /

+0.35 (+3.91%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

VRM Vroom
$69.34 /

+4.45 (+6.86%)

VREX Varex Imaging
$15.99 /

-0.29 (-1.78%)

SDC SmileDirectClub
$9.30 /

+0.35 (+3.91%)

RVLV Revolve Group
$19.49 /

+0.8 (+4.28%)

ONEM One Medical
$27.60 /

-0.87 (-3.06%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

FOSL Fossil
$4.64 /

-0.18 (-3.73%)

ENS EnerSys
$74.33 /

+0.195 (+0.26%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

VRM Vroom
$69.34 /

+4.45 (+6.86%)

SDC SmileDirectClub
$9.30 /

+0.35 (+3.91%)

RVLV Revolve Group
$19.49 /

+0.8 (+4.28%)

ONEM One Medical
$27.60 /

-0.87 (-3.06%)

LYFT Lyft
$30.58 /

-0.065 (-0.21%)

ENS EnerSys
$74.33 /

+0.195 (+0.26%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

Earnings
Fossil sees Q3 worldwide sales down 35% to 45% » 18:57
08/12/20
08/12
18:57
08/12/20
18:57
FOSL

Fossil

$4.64 /

-0.18 (-3.73%)

The company…

The company "currently anticipates that third quarter worldwide net sales will decline in the range of 35% to 45%, reflecting continued contraction in retail and wholesale, partly offset by ongoing strength in e-commerce channels."

ShowHide Related Items >><<
FOSL Fossil
$4.64 /

-0.18 (-3.73%)

FOSL Fossil
$4.64 /

-0.18 (-3.73%)

11/07/19 KeyBanc
Fossil turnaround 'has not manifested,' says KeyBanc
11/07/19 KeyBanc
Fossil downgraded to Sector Weight from Overweight at KeyBanc
FOSL Fossil
$4.64 /

-0.18 (-3.73%)

FOSL Fossil
$4.64 /

-0.18 (-3.73%)

Earnings
Fossil reports Q2 EPS (44c) vs. (15c) last year » 18:56
08/12/20
08/12
18:56
08/12/20
18:56
FOSL

Fossil

$4.64 /

-0.18 (-3.73%)

Reports Q2 revenue…

Reports Q2 revenue $259.0M vs. $501.4M last year. Reports Q2 gross margin 54.3%, up 140bps from last year. The company states: "The year-over-year (revenue decline primarily reflects COVID-19 related impacts on a global basis, including retail and wholesale closures, throughout much of the quarter." CEO Kosta Karsotis says: "Our second quarter results were impacted by broad-based global store closures due to COVID-19 throughout much of the quarter. Our teams have responded quickly and executed well in the face of significant COVID-19 impacts. In navigating this challenging environment, we have taken aggressive actions to increase liquidity and reduce costs, and further engaged with our consumers through digital initiatives and product innovation. Importantly, we are maintaining our focus on the strategic priorities we outlined at the beginning of 2020, including the acceleration of our cost reduction actions through NWF 2.0 and the expansion of our digital capabilities to help drive continued growth in the e-commerce channel."

ShowHide Related Items >><<
FOSL Fossil
$4.64 /

-0.18 (-3.73%)

FOSL Fossil
$4.64 /

-0.18 (-3.73%)

11/07/19 KeyBanc
Fossil turnaround 'has not manifested,' says KeyBanc
11/07/19 KeyBanc
Fossil downgraded to Sector Weight from Overweight at KeyBanc
FOSL Fossil
$4.64 /

-0.18 (-3.73%)

FOSL Fossil
$4.64 /

-0.18 (-3.73%)

Hot Stocks
Disney World actors agree to return to work, says union » 18:46
08/12/20
08/12
18:46
08/12/20
18:46
DIS

Disney

$131.74 /

+1.17 (+0.90%)

The Actors' Equity…

The Actors' Equity Association, the national labor union representing more than 51,000 professional actors and stage managers in live theatre, released the following statement regarding reports that Walt Disney World has agreed to provide space for an on-site center for COVID testing at Walt Disney World: "We have been consistent that testing is an important part of ensuring a safe workplace for Equity performers, and today, I'm pleased to see that Disney World has agreed," said Kate Shindle, President of Actors' Equity Association. "With the news that Disney will make testing available for Equity performers and others in the park, I'm happy to announce that Equity's executive committee has signed a memorandum of understanding with Disney for Equity performers to return." On June 23, Disney announced plans to recall members for rehearsals the following week.On June 25 Equity made a public statement that actors need to be tested because actors cannot practice social distancing throughout their workday. The following day, on June 26, Walt Disney World rescinded all of its recall notices for Equity members. Equity has recently approved safety plans for Diana: A True Musical Story, and two theatres in Massachusetts. All the safety plans included testing. Equity's demands for testing were featured in more than 2,300 articles, including in CNN, The Washington Post, New York Times and Associated Press. The union made over 80 posts on social media social media with a reach of 20.9 million.

ShowHide Related Items >><<
DIS Disney
$131.74 /

+1.17 (+0.90%)

DIS Disney
$131.74 /

+1.17 (+0.90%)

08/05/20
Fly Intel: Top five analyst upgrades
08/05/20 JPMorgan
Disney remains top pick in media post Q3 results at JPMorgan
08/05/20 Needham
Needham says still 'too early' to buy Disney, keeps Hold rating after earnings
08/05/20 BMO Capital
Disney price target raised to $150 from $140 at BMO Capital
DIS Disney
$131.74 /

+1.17 (+0.90%)

DIS Disney
$131.74 /

+1.17 (+0.90%)

DIS Disney
$131.74 /

+1.17 (+0.90%)

DIS Disney
$131.74 /

+1.17 (+0.90%)

Hot Stocks
Babcock & Wilcox names Jimmy B. Morgan COO » 18:39
08/12/20
08/12
18:39
08/12/20
18:39
BW

Babcock & Wilcox

$2.94 /

-0.05 (-1.67%)

Babcock & Wilcox…

Babcock & Wilcox announced plans to align its market-facing segments and financial reporting under three new brands--B&W Environmental, B&W Renewable and B&W Thermal--that better reflect its core markets, products and strategies. The re-branding is expected to improve the Company's organizational structure to support its growth as B&W expands its global sales team and geographic presence and pursues strategic investments in new technologies. As part of the re-branding of its product and service offerings, B&W's new branding is designed to highlight its comprehensive offerings and unique market position to support sustainable energy and industrial infrastructure. The Company's market-facing strategy and branding take effect immediately, and B&W expects to begin reporting its financial results under these new segments starting with its full-year 2020 results. As part of this initiative, B&W has named Jimmy B. Morgan as Chief Operating Officer, effective immediately. In this role, Morgan will be responsible for the Company's strategic and operational performance under each of the new brands and growth platforms. Morgan joined B&W in February 2016 and most recently held the position of Senior Vice President, The Babcock & Wilcox Company, leading B&W's aftermarket, new-build and environmental products and services businesses world-wide.

ShowHide Related Items >><<
BW Babcock & Wilcox
$2.94 /

-0.05 (-1.67%)

BW Babcock & Wilcox
$2.94 /

-0.05 (-1.67%)

Earnings
Babcock & Wilcox reports Q2 EPS (39c), one estimate (61c) » 18:39
08/12/20
08/12
18:39
08/12/20
18:39
BW

Babcock & Wilcox

$2.94 /

-0.05 (-1.67%)

Reports Q2 revenue…

Reports Q2 revenue $135.4M, one estimate $111.9M. "Despite the challenges presented by COVID-19, this is an exciting time for B&W," said Kenneth Young, B&W's Chief Executive Officer. "Following the financing agreement we announced in May, we're moving forward with our strategy to achieve long-term growth and leverage market trends. Our organizational re-alignment and re-branding reflect our mission to provide renewable energy and environmental solutions to customers around the world as we leverage our global strengths and proven, industry-leading technologies. We expect growth from our expanding global pipeline and improved operational execution to drive significant earnings growth throughout 2021 and beyond."

ShowHide Related Items >><<
BW Babcock & Wilcox
$2.94 /

-0.05 (-1.67%)

Earnings
JOYY sees Q3 revenue RMB 5.85B - RMB 6.00B, up 26.7% to 29.9% from last year  18:33
08/12/20
08/12
18:33
08/12/20
18:33
YY

JOYY

$82.19 /

+4.59 (+5.91%)

 
ShowHide Related Items >><<
YY JOYY
$82.19 /

+4.59 (+5.91%)

YY JOYY
$82.19 /

+4.59 (+5.91%)

07/10/20 JPMorgan
JOYY price target raised to 'Street high' $125 at JPMorgan
06/15/20 Credit Suisse
JOYY price target raised to $124 from $88 at Credit Suisse
05/21/20 Benchmark
JOYY price target raised to $86 from $78 at Benchmark
05/20/20 Morgan Stanley
Morgan Stanley upgrades JOYY to Overweight on stepping up monetization of Likee
YY JOYY
$82.19 /

+4.59 (+5.91%)

YY JOYY
$82.19 /

+4.59 (+5.91%)

YY JOYY
$82.19 /

+4.59 (+5.91%)

Earnings
JOYY reports Q2 EPS 79c, consensus 69c » 18:32
08/12/20
08/12
18:32
08/12/20
18:32
YY

JOYY

$82.19 /

+4.59 (+5.91%)

Reports Q2 revenue…

Reports Q2 revenue $826.6M, consensus $739.75M. Average mobile MAUs of Likee increased by 86.2% to 150.3 million from 80.7 million in the corresponding period of 2019. Average mobile MAUs of global live streaming services increased by 20.4% to 102.3 million from 85.0 million in the corresponding period of 2019. Average mobile MAUs of video communication service was 204.4 million. Total number of paying users5 of YY decreased by 2.2% to 4.1 million from 4.2 million in the corresponding period of 2019, primarily due to the impact of COVID-19.

ShowHide Related Items >><<
YY JOYY
$82.19 /

+4.59 (+5.91%)

YY JOYY
$82.19 /

+4.59 (+5.91%)

07/10/20 JPMorgan
JOYY price target raised to 'Street high' $125 at JPMorgan
06/15/20 Credit Suisse
JOYY price target raised to $124 from $88 at Credit Suisse
05/21/20 Benchmark
JOYY price target raised to $86 from $78 at Benchmark
05/20/20 Morgan Stanley
Morgan Stanley upgrades JOYY to Overweight on stepping up monetization of Likee
YY JOYY
$82.19 /

+4.59 (+5.91%)

YY JOYY
$82.19 /

+4.59 (+5.91%)

YY JOYY
$82.19 /

+4.59 (+5.91%)

Hot Stocks
Cisco CEO: We'll be fine on the other side of the pandemic » 18:27
08/12/20
08/12
18:27
08/12/20
18:27
CSCO

Cisco

$48.08 /

+0.86 (+1.82%)

In an interview on…

In an interview on CNBC's Mad Money, Chuck Robbins said he was "confident" the company would find a "great replacement" for CFO Kelly Kramer. Kramer has agreed to stay on until a successor is found, he noted. WebEx grew double digits in Q4, but it's a small part of the business, Robbins said. The company saw strength at the high end of enterprise and Federal during Q4, but had heavy logistic costs during the quarter. Robbins expects margins to improve over the next few years as the company moves towards software.

ShowHide Related Items >><<
CSCO Cisco
$48.08 /

+0.86 (+1.82%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

08/07/20 Cleveland Research
Cisco checks point to 'disappointing pace' of recovery, says Cleveland Research
07/24/20 Wolfe Research
Cisco initiated with an Outperform at Wolfe Research
07/16/20
Fly Intel: Top five analyst downgrades
07/16/20 JPMorgan
JPMorgan downgrades Cisco, expects 'limited investor enthusiasm'
CSCO Cisco
$48.08 /

+0.86 (+1.82%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

CSCO Cisco
$48.08 /

+0.86 (+1.82%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.